The present invention relates to new salts of the renin inhibitor Aliskiren in a crystalline or amorphous form, processes for the manufacture of the new Aliskiren salts in a crystalline form, and a process for forming salts of Aliskiren by freeze-drying a
-
Page/Page column 26
(2011/09/15)
SOLID STATE FORMS OF ALISKIREN COMPOUNDS
The invention relates to solid states of pharmaceutically acceptable compounds of aliskiren, and processes for preparation thereof. The invention further provides pharmaceutical formulations comprising the amorphous or crystalline forms of pharmaceuticall
-
Page/Page column 9
(2010/08/08)
More Articles about upstream products of 1327153-75-2
Get Best Price for1327153-75-2(2S),(4S),(5S),(7S)-N-(3-amino-2,2-dimethyl-3-oxopropyl)-2,7-di(1-methylethyl)-4-hydroxy-5-amino-8-[4-methoxy-3-(3-methoxy-propoxy)phenyl]-octanamide phosphate